Viewing Study NCT01892527

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-03-05 @ 2:31 PM
Study NCT ID: NCT01892527
Status: COMPLETED
Last Update Posted: 2022-09-09
First Post: 2013-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects
Sponsor: Armando Santoro, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer Metastatic View
None C-met Overexpression View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colorectal Cancer Metastatic View
None wild type KRAS View
None C-met overexpression View
None Tivantinib View
None Cetuximab View